Loading…
How much revenue Cellebrite DI already has under contract, how fast it converts, and who it is with.
Data as of .
| Quarter end | Backlog (RPO) | TTM revenue | Coverage | Customer prepayments |
|---|---|---|---|---|
| 30 Jun 2025 | $345M | n/a | n/a | $227M |
| 31 Dec 2024 | $344M | $401M | 0.9 yrs | $262M |
| 31 Dec 2022 | $276M | $271M | 1.0 yrs | $195M |
| 31 Dec 2021 | $232M | $246M | 0.9 yrs | $159M |
| 31 Dec 2020 | $173M | $195M | 0.9 yrs | $139M |
Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.